Key facts
- This page summarizes Gary W. Pace's Form 4 filing for Cardiff Oncology, Inc. (CRDF).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jul 2025, 16:05.
Gary W. Pace - 30 Jul 2025 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)
- Reporting relationship
- Director
- Issuer ticker
- CRDF
- Reported as of
- 30 Jul 2025
- Net transaction value
- +$710,500
- SEC form
- 4
- Accepted by SEC
- 31 Jul 2025, 16:05:05 UTC
- Prior SEC filing
- 27 Jun 2025
- Next SEC filing
- 15 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gary Pace
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gary W. Pace filed Form 4 for Cardiff Oncology, Inc. (CRDF) on 31 Jul 2025.
Change
- Previous filing in this sequence was filed on 27 Jun 2025.
- Current net transaction value: +$710,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001184778
Primary reporting owner
PACE GARY W
- Relationship
- Director
- Address
- C/O CARDIFF ONCOLOGY, INC., 11055 FLINTKOTE AVENUE, SAN DIEGO
- Signature
- /s/ Gary Pace
- Signature date
- 31 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRDF
transaction
Common Stock
Purchase
- Transaction value
- $673,750
- Shares
- +275,000
- Change %
- +26%
- Price
- $2.45
- Shares after
- 1,330,676
- Date
- 30 Jul 2025
- Ownership
- Direct
CRDF
transaction
Common Stock
Purchase
- Transaction value
- $36,750
- Shares
- +15,000
- Change %
- +1.1%
- Price
- $2.45
- Shares after
- 1,345,676
- Date
- 30 Jul 2025
- Ownership
- By minor child
* marks a reported price that did not pass the local price check.